Appropriate Dosing for ABHR Cream and Agitation Management
The recommended dose for ABHR cream is not established as effective, as studies show that lorazepam, diphenhydramine, and haloperidol in topical gel form are not absorbed in sufficient quantities to be therapeutically effective for nausea and vomiting. 1
Topical ABHR Cream Ineffectiveness
Research demonstrates that when applied topically as a gel:
- No lorazepam or haloperidol was detected in plasma samples (detection limit 0.05 ng/mL)
- Diphenhydramine was only detected at subtherapeutic levels in some subjects
- No clinical effects were observed in study participants 1
Recommended Parenteral Dosing for Agitation Management
For managing agitation or sedation, the following parenteral dosing is recommended based on guidelines:
First-line options:
Lorazepam: 1 mg subcutaneous or intravenous (up to 2 mg maximum) 2
- Use lower doses (0.25-0.5 mg) in older, frail patients or those with COPD
- FDA warning: Maximum initial oral dose should not exceed 2 mg in elderly patients 3
Haloperidol: 5 mg intramuscular for severe agitation 4
Combination therapy:
- Haloperidol 5 mg + Lorazepam 2 mg intramuscular provides superior sedation compared to either medication alone 4, 5
- This combination has demonstrated more rapid tranquilization than either agent alone
- Physical compatibility studies confirm this combination is stable in the same syringe 6
Important Considerations
Safety precautions:
- Monitor for respiratory depression, especially when combining benzodiazepines with other CNS depressants 3
- Observe for extrapyramidal symptoms, particularly with haloperidol 2
- Use caution in elderly patients who may be more susceptible to sedative effects 3
- FDA black box warning: Concomitant use of benzodiazepines and opioids may result in profound sedation, respiratory depression, coma, and death 3
Alternative options:
- Olanzapine 5-10 mg IM is now considered first-line by some guidelines due to superior efficacy and safety profile 4
- Midazolam has shown more rapid sedation (18.3 minutes) compared to lorazepam (32.2 minutes) or haloperidol (28.3 minutes) 2
Conclusion
While the combination of lorazepam 2 mg, diphenhydramine 25 mg, and haloperidol 2 mg is commonly referenced, this specific formulation as a topical cream lacks evidence of absorption and efficacy. For parenteral administration in agitation management, the combination of haloperidol 5 mg with lorazepam 2 mg is supported by evidence for superior and more rapid tranquilization compared to either agent alone.